![Kevin Sarney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Sarney
Financieel Directeur/CFO bij
ATARA BIOTHERAPEUTICS, INC.
Profiel
Kevin G.
Sarney is Chief Financial Officer at Atara Biotherapeutics, Inc. since 2026.
Formerly, Mr. Sarney was Chief Accounting Officer at NitroMed, Inc., Vice President-Finance & Administration at Avaxia Biologics, Inc. from 2013 to 2014, and Chief Accounting Officer & Vice President-Finance at Enumeral Biomedical Holdings, Inc. from 2014 to 2018.
Education includes an MBA from Boston University, graduate studies at Suffolk University, and undergraduate studies at the University of Hartford.
Actieve functies van Kevin Sarney
| Bedrijven | Functie | Begin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Financieel Directeur/CFO | 26-06-2026 |
Eerdere bekende functies van Kevin Sarney
| Bedrijven | Functie | Einde |
|---|---|---|
| ENUMERAL BIOMEDICAL HOLDINGS INC | Algemeen Directeur | - |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Financieel Directeur/CFO | 01-07-2014 |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Comptroller/Controller/Auditor | 27-01-2009 |
Opleiding van Kevin Sarney
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
23
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Avaxia Biologics, Inc.
Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Enumeral Biomedical Holdings, Inc.
 Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Develops novel antibody immunotherapies designed to help immune system attack diseased cells | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hartford
 University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
